From The Guardian: “UK regulators have given the go-ahead for the first clinical trial of the use of the psychedelic drug dimethyltriptamine (DMT) to treat depression. The trial will initially give the drug – known as the “spirit molecule” for the powerful hallucinogenic trips it induces – to healthy individuals, but it is expected to be followed by a second trial in patients with depression, where DMT will be given alongside psychotherapy…”
Read More“After Denver paved the way by decriminalizing mushrooms, a major city in California is moving on other psychedelics like ayahuasca, ibogaine, and mescaline cacti. Now Oakland is calling for decriminalization of other psychedelics like mescaline cacti, ayahuasca and ibogaine…”
Read More